Skip to main content
Log in

Screening of Tissue Transglutaminase Antibody in Healthy Blood Donors for Celiac Disease Screening in the Turkish Population

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Celiac disease (CD) is a disease having the characteristic pathology of the mucosa of the small intestine. The prevalence of CD in the Turkish population has not been investigated previously. The present study was designed to determine the prevalence of CD in healthy blood donors. Serum samples of 2000 healthy blood donors presenting to Hacettepe University Faculty of Medicine Hospital Blood Bank were tested for tissue transglutaminase (tTG) IgA and IgG antibodies with enzyme-linked immunosorbent assay (ELISA; Euroimmune, Germany). The histopathological findings for the cases with positive serology were evaluated. The distribution of sex was 95.7% male, and 4.3% female. The mean age was 33±9. Among 2000 donors, 23 (1.15%) were positive for tTG IgA antibody and 3 (0.15%) were positive for tTG IgG antibody. None of the samples was positive for both antibodies. Serum total IgA was measured in two cases with only tTG IgG positivity and was found to be low in one case. Twelve subjects positive for tTG agreed to endoscopy and biopsy. Histopathological examination revealed changes classified as Marsh III–II in one, Marsh II in two, Marsh I in seven, and Marsh 0 in two donors. This was the first study conducted to determine the prevalence of tTG positivity in the Turkish population. The tTG antibody positivity prevalence in healthy blood donors was as high as 1.3%. This study shows that the prevalence of CD in the Turkish population is relatively high in comparison to that in the Western world.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Farrell RJ, Kelly CP: Celiac sprue and refractory sprue. In Sleisenger & Fordtran's Gastrointestinal and Liver Disease Pathophysiology/Diagnosis/Management, Vol. 11, 7th ed. M Feldman, LS Friedman, MH Sleisenger (eds). Philadelphia, Elsevier Science, 2002, pp 1817–1841

    Google Scholar 

  2. Farrell RJ, Kelly CP: Diagnosis of celiac sprue. Am J Gastroenterol 96:3237–3246, 2001

    Google Scholar 

  3. Farrell RJ, Kelly CP: Celiac sprue. N Engl J Med 346(3):180–188, 2002

    Google Scholar 

  4. Shand AG, Ciclitira PJ: Celiac disease. Clin Perspect Gastroenterol 277–283, 2002

  5. Fasano A, Catassi C: Current approaches to diagnosis and treatment of celiac disease: An evolving spectrum. Gastroenterology 120:636–651, 2001

    Google Scholar 

  6. Parnell ND, Ciclitira PJ: Review article: Coeliac disease and its management. Aliment Pharmacol Ther 13:1–13, 1999

    Google Scholar 

  7. American Gastroenterological Association Medical Position Statement: Celiac sprue. Gastroenterology 120:1522–1525, 2001

    Google Scholar 

  8. Ivarsson A, Persson LA, Juto P, et al.: High prevalence of undiagnosed coeliac disease in adults: A Swedish population based study. Intern Med 245:63–68, 1999

    Google Scholar 

  9. Volta U, Bellentani S, Bianchi BF, et al.: High prevalence of celiac disease in Italian general population. Dig Dis Sci 46(7):1500–1505, 2001

    Google Scholar 

  10. Hovell CJ, Collet JA, Vautier G, et al.: High prevalence of coeliac disease in a population-based study from Western Australia: A case for screening? MJA 175:247–250, 2001

    Google Scholar 

  11. Riestra S, Fernandez E, Rodrigo L, et al.: Prevalence of coeliac disease in the general population of northern Spain. Scand J Gastroenterol 4:398–402, 2000

    Google Scholar 

  12. Catassi C, Ratsch IM, Gandolfi L, et al.: Why is coeliac disease endemic in the people of the Sahara? Lancet 354(9179):647–648, 1999

    Google Scholar 

  13. Shahbazkhani B, Malekzadeh R, Sotoudeh M, et al.: High prevalence of coeliac disease in apparently healthy Iranian blood donors. Eur J Gastroenterol Hepatol 15:475–478, 2003

    Google Scholar 

  14. Marsh MN: Gluten, major histocompatibility complex, and small intestine. Gastroenterology 102:330–354, 1992

    Google Scholar 

  15. Ferguson A: Celiac disease, an eminently treatable condition, may be underdiagnosed in the United States. Am J Gastroenterol 92(8):1252–1254, 1997

    Google Scholar 

  16. Corrao G, Corazza GR, Bagnardi V, et al.: Mortality in patients with coeliac disease and their relatives: A cohort study. Lancet 358:356–361, 2001

    Google Scholar 

  17. Guandalini S, Gokhale R: Update on immunologic basis of celiac disease. Curr Opin Gastroenterol 18:95–100, 2002

    Google Scholar 

  18. Akar H, Sokucu S, Suoglu O, et al.: Colyak hastalýgý olans Turk Cocuklarýnda genotip ile klinik bulgularýn iliskisi. Antalya, UGH, 2001, s21

    Google Scholar 

  19. Dahele AVM, Aldhous MC, Humphreys K, et al.: Serum IgA tissue transglutaminase antibodies in celiac disease and other gastrointestinal diseases. Q J Med 94:195–205, 2001

    Google Scholar 

  20. Sblattero D, Berti I, Trevisiol C, et al.: Human recombinant tissue transglutaminase ELISA: An innovative diagnostic assay for celiac disease. Am J Gastroenterol 95:1253–1257, 2000

    Google Scholar 

  21. Dickey W, Hughes DF, McMillan SA: Reliance on serum endomysial antibody testing underestimates the true prevalence of celiac disease by one fifth. Scand J Gastroenterol 35:181–183, 2000

    Google Scholar 

  22. Catassi C, Fanciulli G, D'Appello AR, et al.: Antiendomysium versus antigliadin antibodies in screening the general population for celiac disease. Scand J Gastroenterol 35:732–736, 2000

    Google Scholar 

  23. Trevisiol C, Ventura A, Baldas V, et al.: A reliable screening procedure for coeliac disease in clinical practice. Scand J Gastroenterol 6:679–684, 2002

    Google Scholar 

  24. Not T, Hovarth K, Hill JP, et al.: Celiac disease risk in the USA: High prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol 33:494–498, 1998

    Google Scholar 

  25. Sjöberg K, Eriksson S: Regional differences in coeliac disease prevalence in Scandinavia?. Scand J Gastroenterol 34:41–45, 1999

    Google Scholar 

  26. Rostami K, Mulder JJ, Werre JM, et al.: High prevalence of celiac disease in apparently healthy blood donors suggests a high prevalence of undiagnosed celiac disease in the Dutch population. Scand J Gastroenterol 34:276–279, 1999

    Google Scholar 

  27. Gandolfi L, Pratesi R, Cordoba JCM, et al.: Prevalence of celiac disease among blood donors in Brazil. Am J Gastroenterol 95:689–692, 2000

    Google Scholar 

  28. Hovdenak N, Hovlid E, Asknes L, et al.: High prevalence of asymptomatic coeliac disease in Norway: A study of blood donors. Eur J Gastroenterol Hepatol 11(2):185–187, 1999

    Google Scholar 

  29. Shamir R, Lerner A, Shinar E, et al.: The use of a single serological marker underestimates the prevalence of celiac disease in Israel: A study of blood donors. Am J Gastroenterol 97:2589–2594, 2002

    Google Scholar 

  30. Gomez JC, Selvaggio G, Pizarro B, et al.: Value of a screening algorithm for celiac disease using tissue transglutaminase antibodies as first level in a population-based study. Am J Gastroenterol 97:2785–2790, 2002

    Google Scholar 

  31. Fasano A, Berti I, Gerarduzzi T, et al.: Prevalence of celiac disease in at-risk and not-at-risk groups in the United States. Arch Intern Med 163:286–292, 2003

    Google Scholar 

  32. Bingley PJ, Williams AJ, Norcross AJ, et al.: Undiagnosed coeliac disease at age seven: Population based prospective birth cohort study. BMJ 328(7435):322–323, 2004

    Google Scholar 

  33. West J, Logan RF, Hill PG, et al.: Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 52(7):960–965, 2003

    Google Scholar 

  34. Maki M, Mustalahti K, Kokkonen J, et al.: Prevalence of celiac disease among children in Finland. N Engl J Med 348(25):2517–2524, 2003

    Google Scholar 

  35. Cataldo F, Lio D, Marino V, et al., the Working Group on Celiac Disease of SIGEP and Club del Tenue: IgG1 antiendomysium and IgG antitissue tranglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency. Gut 47:366–369, 2000

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tatar, G., Elsurer, R., Simsek, H. et al. Screening of Tissue Transglutaminase Antibody in Healthy Blood Donors for Celiac Disease Screening in the Turkish Population. Dig Dis Sci 49, 1479–1484 (2004). https://doi.org/10.1023/B:DDAS.0000042250.59327.91

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:DDAS.0000042250.59327.91

Navigation